American Society of Clinical Oncology (ASCO) shared a post on LinkedIn:
“Clinical trials remain out of reach for many Americans, with only 7% of patients with cancer participating in clinical trials, according to a new report from ASCO’s State of Cancer Care in America series.
Experts agree that access to trials is a key element in driving progress in cancer care and improving patient outcomes. The study, published in JCO Oncology Practice, highlights long-standing barriers to trial participation and highlights efforts to bridge the accessibility gap.
Title: ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States
Authors: Erin P. Balogh, Laura A. Levit, Joseph M. Unger, Melissa K. Accordino, David D. Chism, M. Kelsey Kirkwood, Helen M. Parsons, Manali I. Patel, Jeffery M. Peppercorn, Blase N. Polite, Mina S. Sedrak, Priyanka Sharma, Ishwaria M. Subbiah, Jennifer S. Temel, K. Robin Yabroff, Raymond U. Osarogiagbon
Read the Full Article on JCO Oncology Practice
Robin Zon, Chair of ASCO Society Board 2025-2026, President of ASCO 2024-2025, shared this post, adding:
“This is absolutely one way to accomplish increasing our accrual. If we look at Australia and specifically Dr. Sabeson‘s work, he was able to work with the government to decentralized clinical trials. So this serves as a model that potentially can be used to help facilitate this opportunity.”
More posts featuring ASCO.
